Survival analysis of patients with brain metastases at initial breast cancer diagnosis over the last decade

ConclusionOver the last decade, the median OS of patients with brain metastases at initial breast cancer diagnosis remained poor; however, a substantial minority survive 5 or more years, with rates higher in patients with HER2-positive tumors. In addition to tumor subtype, OS varied according to age, extracranial metastases, and sociodemographic factors.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research